This book explores how medicines in China's health care system are selected, procured and priced, together with reimbursement systems, the prescribing and usage of drugs, and the role that commercial insurance can play in paying for drugs.
This book presents the findings of systematic research into the healthcare medicine management policies of China. In-depth comprehensive research has been carried out, targeting multiple issues of particular importance in healthcare medicine management, such as the purchasing, pricing, payment, usage, and the function of commercial healthcare insurance in medical payment. The book goes on to put forward policy advice regarding the aforementioned issues.
